Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huri Ozdogan

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Rheumatology|November 18, 2017
Exacerbation of Behçet's syndrome and familial Mediterranean fever with menstruationGul Guzelant, Yesim Ozguler, Sinem Nihal Esatoglu, et al.
Rheumatology International|January 12, 2018
Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studiesGizem Ayan, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Modern Rheumatology Case Reports|August 5, 2023
A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variantsKerem Parlar, Eda Tahir Turanli, Eda Nuhoglu Kantarci, et al.
Annals of the Rheumatic Diseases|January 30, 2016
Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)Erkan Demirkaya, Cengizhan Acikel, Philip Hashkes, et al.
Internal Medicine Journal|August 21, 2024
Characteristics of arthritis in patients with familial Mediterranean feverSelcan Yenigun, Ali Yagiz Ayla, Mebrure B Yuzbasioglu, et al.
Pediatrics|January 24, 2007
Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statementTilmann Kallinich, Dieter Haffner, Tim Niehues, et al.
Annals of the Rheumatic Diseases|February 27, 2014
FMF50: a score for assessing outcome in familial Mediterranean feverSeza Ozen, Erkan Demirkaya, Ali Duzova, et al.
Annals of the Rheumatic Diseases|June 24, 2020
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trialSeza Ozen, Eldad Ben-Cherit, Ivan Foeldvari, et al.
Internal and Emergency Medicine|July 21, 2017
Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown originRaffaele Manna, Roberto Cauda, Sandro Feriozzi, et al.
Rheumatology (Oxford, England)|June 3, 2022
Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic reviewGuzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|November 18, 2017
Exacerbation of Behçet's syndrome and familial Mediterranean fever with menstruationGul Guzelant, Yesim Ozguler, Sinem Nihal Esatoglu, et al.
Rheumatology International|January 12, 2018
Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studiesGizem Ayan, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Modern Rheumatology Case Reports|August 5, 2023
A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variantsKerem Parlar, Eda Tahir Turanli, Eda Nuhoglu Kantarci, et al.
Annals of the Rheumatic Diseases|January 30, 2016
Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)Erkan Demirkaya, Cengizhan Acikel, Philip Hashkes, et al.
Internal Medicine Journal|August 21, 2024
Characteristics of arthritis in patients with familial Mediterranean feverSelcan Yenigun, Ali Yagiz Ayla, Mebrure B Yuzbasioglu, et al.
Pediatrics|January 24, 2007
Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statementTilmann Kallinich, Dieter Haffner, Tim Niehues, et al.
Annals of the Rheumatic Diseases|February 27, 2014
FMF50: a score for assessing outcome in familial Mediterranean feverSeza Ozen, Erkan Demirkaya, Ali Duzova, et al.
Annals of the Rheumatic Diseases|June 24, 2020
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trialSeza Ozen, Eldad Ben-Cherit, Ivan Foeldvari, et al.
Internal and Emergency Medicine|July 21, 2017
Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown originRaffaele Manna, Roberto Cauda, Sandro Feriozzi, et al.
Rheumatology (Oxford, England)|June 3, 2022
Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic reviewGuzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, et al.
Pageof 5